Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merit Medical Systems Inc (NASDAQ:MMSI)

25.56
Delayed Data
As of Jul 31
 +0.39 / +1.55%
Today’s Change
11.61
Today|||52-Week Range
26.42
+47.49%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$1.1B

Company Description

Merit Medical Systems, Inc. designs, develops, manufactures and markets single-use medical products for interventional and diagnostic procedures. The company operates through two operating segments: Cardiovascular and Endoscopy. The Cardiovascular segment consists of cardiology and radiology devices which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes the embolotherapeutic products acquired through the acquisition of BioSphere Medical, Inc. The Endoscopy segment includes gastroenterology and pulmonology medical devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Merit Medical Systems was founded by Fred P. Lampropoulos, Kent W. Stanger and William Padilla in July 1987 and is headquartered in South Jordan, UT.

Contact Information

Merit Medical Systems, Inc.
1600 West Merit Parkway
South Jordan Utah 84095
P:(801) 253-1600
Investor Relations:
(801) 208-4167

Employees

Shareholders

Mutual fund holders50.40%
Individual stakeholders5.04%
Other institutional39.85%

Top Executives

Fred P. LampropoulosChairman, President & Chief Executive Officer
Ronald A. FrostChief Operating Officer
Kent W. StangerCFO, Secretary, Treasurer & Director
Joseph PierceChief Information Officer
Justin LampropoulosEVP-Europe, Middle East & Africa Region